Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03938246
What this trial is testing

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Sagimet Biosciences Inc. 142
Not applicableLooking for participantsNCT06706856
What this trial is testing

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

Who this might be right for
MASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of California, San Diego 120
Not applicableUnknownNCT06325254
What this trial is testing

Clinical Characteristics of Metabolic Associated Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver DiseaseClinical Features
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3,000
Large-scale testing (Phase 3)Study completedNCT02216552
What this trial is testing

Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

Who this might be right for
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
University of Manitoba 10
Not applicableStudy completedNCT06492330
What this trial is testing

Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)ObesityDiabetes Mellitus, Type 2
Shanghai Jiao Tong University School of Medicine 62
Not applicableUnknownNCT06541132
What this trial is testing

Positive Association of US-FLI With the Severity of CAD

Who this might be right for
Coronary Artery Disease of Significant Bypass GraftMetabolic Dysfunction-associated Fatty Liver DiseaseSYNTAX Score+1 more
Chongqing Medical University 190
Not applicableLooking for participantsNCT07246421
What this trial is testing

Glucagon Resistance in Patients With MASLD and T2DM

Who this might be right for
Metabolic Associated Fatty Liver DiseaseType 2 Diabetes (T2DM)
University of Aarhus 24
Not applicableLooking for participantsNCT06661655
What this trial is testing

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Who this might be right for
Metabolic Syndrome XFatty LiverMASH - Metabolic Dysfunction-Associated Steatohepatitis+4 more
E-Scopics 120
Not applicableStudy completedNCT06491342
What this trial is testing

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver, Nonalcoholic
Phramongkutklao College of Medicine and Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT05984745
What this trial is testing

Effect of CoQ10 on the Outcome of MAFLD Patients

Who this might be right for
Fatty LiverNAFLD
Ain Shams University 60
Not applicableStudy completedNCT07763626
What this trial is testing

Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Syndrome
University of Genova 112
Not applicableUnknownNCT04861012
What this trial is testing

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Who this might be right for
Steatohepatitis, Nonalcoholic
Assiut University 360
Not applicableLooking for participantsNCT06824974
What this trial is testing

Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer

Who this might be right for
Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight
University of California, San Diego 50
Not applicableLooking for participantsNCT06585982
What this trial is testing

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

Who this might be right for
Fatty Liver Disease
Universitas Diponegoro 50
Not applicableLooking for participantsNCT06883578
What this trial is testing

Effect of Low Valine Diet on Body Weight and Metabolic Parameters

Who this might be right for
Overweight/obesityMetabolic Associated Fatty Liver DiseaseMetabolic Diseases
Shanghai Zhongshan Hospital 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT06920316
What this trial is testing

Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
St. George's Hospital, London 100
Early research (Phase 1)Looking for participantsNCT07334080
What this trial is testing

ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Eccogene 72
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableLooking for participantsNCT07187830
What this trial is testing

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Who this might be right for
Chronic Kidney Disease in Type 2 DiabetesObesity & Overweight
University of Alberta 52
Not applicableLooking for participantsNCT07241195
What this trial is testing

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

Who this might be right for
NAFLD and NASHNAFLD( Non-alcoholic Fatty Liver Disease )NAFLD Cirrhosis
The Affiliated Hospital of Hangzhou Normal University 20,000
Next Page